With the analysis among 88 patents, we discovered top 31 key players by total patent application. OncoImmune, Inc., AroCell AB, Akamara Therapeutics, Inc. are dominant in this area. They take 26.14% of the total patent filing.
Massachusetts, United States
Patent: 6
Nordrhein-Westfalen, Germany
Patent: 5
California, United States
Patent: 3
With the analysis among 9 patents, we discovered top 2 start-ups by total patent application.
Massachusetts, United States
Patent: 1
With the analysis among related 53 patents applied in the last 5 years. We discover 28 most active companies in this area. The fast-growing OncoImmune, Inc., University of Maryland Greenebaum Cancer Center, Biond Biologics Ltd. take 35.85% of patent filing during this period.
District of Columbia, United States
Patent: 2
New York, United States
Patent: 2
undefined undefined
Patent: 1
Beijing Yuxintang Institute of Traditional Chinese Medicine
Beijing Shi, China
Patent: 1
With the analysis among related 53 patents in last 5 years, we discover 20 new entrants. OncoImmune, Inc., University of Maryland Greenebaum Cancer Center, Biond Biologics Ltd. are the most active new entrants in this area.
District of Columbia, United States
Patent: 2
undefined undefined
Patent: 1
Beijing Yuxintang Institute of Traditional Chinese Medicine
Beijing Shi, China
Patent: 1
District of Columbia, United States
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among 59 patents, we discovered top 9 universities and scientific research institutions by total patent application. University of Southern California, The Scripps Research Institute, Cornell University are dominant in this area. They take 40.68% of the total patent filing.
California, United States
Patent: 7
California, United States
Patent: 4
New York, United States
Patent: 3
Zhejiang Sheng, China
Patent: 2
Virginia, United States
Patent: 1
North Carolina, United States
Patent: 1
Iwate-ken, Japan
Patent: 1